Kevin Kettler, SVP marketing, U.S. Pharmaceutical at McKesson, took Drug Store News on a guided tour of the McKesson ideaShare show floor following the Opening General Session yesterday. The five stations included on the tour are designed to increase access to patients, help bring those patients into the store and maximize these patients by offering new services to bring in new revenue.
Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.
Pharmacy organizations have written a joint letter to the Food and Drug Administration asking officials to delay enforcement of a July 1 electronic product-tracing deadline for prescription drug dispensers.
Ateb, a provider of pharmacy patient care solutions, has announced the formation of its inaugural Community Pharmacy Advisory Board, comprised of pharmacy leaders who will serve as an “internal institute” within the Ateb organization.
Despite high-profile efforts to implement abuse-deterrent labels and properties on brand-name opioids, advisory company Avalere Health’s latest research notes a key blind spot in the efforts — accessibility.